Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1997 1
2000 1
2001 1
2002 1
2003 2
2004 4
2005 4
2006 9
2007 8
2008 4
2009 4
2010 3
2011 4
2012 8
2013 1
2014 4
2015 6
2016 6
2017 5
2018 3
2019 5
2020 2
2021 2
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 22218624

79 results
Results by year
Filters applied: . Clear all
Page 1
Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH. Robbins DC, et al. Clin Ther. 2007 Nov;29(11):2349-64. doi: 10.1016/j.clinthera.2007.11.016. Clin Ther. 2007. PMID: 18158076 Clinical Trial.
A treatment strategy implementing combination therapy with sitagliptin and metformin results in superior glycaemic control versus metformin monotherapy due to a low rate of addition of antihyperglycaemic agents.
Olansky L, Reasner C, Seck TL, Williams-Herman DE, Chen M, Terranella L, Mehta A, Kaufman KD, Goldstein BJ. Olansky L, et al. Diabetes Obes Metab. 2011 Sep;13(9):841-9. doi: 10.1111/j.1463-1326.2011.01416.x. Diabetes Obes Metab. 2011. PMID: 21535346 Clinical Trial.
79 results